Herb formula "Fufangqishe-Pill" prevents upright posture-induced intervertebral disc degeneration at the lumbar in rats

Journal of Pharmacological Sciences

Volumn 113, Issue 1, 2010, Pages 23-31

  Liang, Qian Qian ^a   Xi, Zhi Jie ^a   Bian, Qin ^a   Cui, Xue Jun ^a   Li, Chen Guang ^a   Hou, Wei ^a   Shi, Qi ^a   Wang, Yong Jun ^a  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Chronic low back pain; Extracellular matrix; Fufangqishe Pill; Lumbar intervertebral disc degeneration

Indexed keywords

COLLAGEN; COLLAGEN TYPE 10; COLLAGEN TYPE 10 ALPHA 1; COLLAGEN TYPE 2; COLLAGEN TYPE 2 ALPHA 1; COLLAGENASE 3; FUFANGQISHE; HERBACEOUS AGENT; INTERLEUKIN 1BETA; MESSENGER RNA; STROMELYSIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INTERVERTEBRAL DISK DEGENERATION; LUMBAR DISK; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; STANDING; UPREGULATION;

EID: 77953509421     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.09231FP     Document Type: Article

References (37)

1. Hangai M, Kaneoka K, Hinotsu S, Shimizu K, Okubo Y, Miyakawa S, et al. Lumbar Intervertebral Disk Degeneration in Athletes. Am J Sports Med. 2009;37:149-155.
2. Waris E, Eskelin M, Hermunen H, Kiviluoto O, Paajanen H. Disc degeneration in low back pain: a 17-year follow-up study using magnetic resonance imaging. Spine. 2007;32:681-684.
3. Borghouts JA, Koes BW, Bouter LM. The clinical course and prognostic factors of non-specific neck pain: a systematic review. Pain. 1998;77:1-13.
4. Centeno CJ, Fleishman J. Degenerative disc disease and pre-existing spinal pain. Ann Rheum Dis. 2003;62:371-372.
5. Zhou Q, Wang YJ, Shi Q, Sun P, Zhou CJ, Hu ZJ, et al. [Effects of Yiqi Huayu Recipe and its decomposed formulas on apoptosisrelated factors of anulus fibrosus cells in rats.] Zhong Xi Yi Jie He Xue Bao. 2005;3:466-469. (text in Chinese with English abstract)
6. Liang QQ, Zhou Q, Zhang M, Hou W, Cui XJ, Li CG, et al. Prolonged upright posture induces above degenerative changes in intervertebral discs in rat lumbar spine. Spine. 2008;33:2052-2058.
7. Zhang YQ, Liu XH, Zhang N, Liu M. [Studies on the quality control of compound Qishe tablets.] Sinopharm Medicine Shi-Zhen. 2008;19:977-978. (in Chinese)
8. Longo UG, Ripalda P, Denaro V, Forriol F. Morphologic comparison of cervical, thoracic, lumbar intervertebral discs of cynomolgus monkey (Macaca fascicularis). Eur Spine J. 2006;15:1845-1851.
9. Garnero P, Sornay-Rendu E, Arlot M, Christiansen C, Delmas PD. Association between spine disc degeneration and type II collagen degradation in postmenopausal women. Arthritis Rheum. 2004;50:3137-3144.
10. Oegema TR Jr. The role of disc cell heterogeneity in determining disc biochemistry: a speculation. Biochem Soc Trans. 2002;30: 839-844.
11. Sive JI, Baird P, Jeziorsk M, Watkins A, Hoyland JA, Freemont AJ. Expression of chondrocyte markers by cells of normal and degenerate intervertebral discs. Mol Pathol. 2002;55:91-97.
12. Yang CL, Rui H, Mosler S, Notbohm H, Sawaryn A, Müller PK. Collagen II from articular cartilage and annulus fibrosus: structural and functional implication of tissue specific posttranslational modifications of collagen molecules. Eur J Biochem. 1993; 213:1297-1302.
13. Gruber HE, Hanley EN Jr. Recent advances in disc cell biology. Spine. 2003;28:186-193.
14. Roughley PJ. Biology of intervertebral disc aging and degeneration: involvement of the extracellular matrix. Spine. 2004;29: 2691-2699.
15. Lauer-Fields JL, Tuzinski KA, Shimokawa K, Nagase H, Fields GB. Hydrolysis of triple-helical collagen peptide models by matrix metalloproteinases. J Biol Chem. 2000;275:13282-13290.
16. Borghaei RC, Rawlings PL Jr, Javadi M, Woloshin J. NF-κB binds to a polymorphic repressor element in the MMP-3 promoter. Biochem Biophys Res Commun. 2004;316:182-188.
17. Le Maitre CL, Freemont AJ, Hoyland JA. The role of interleukin-1 in the pathogenesis of human Intervertebral disc degeneration. Arthritis Res Ther. 2005;7:R732-R745.
18. Sobajima S, Shimer AL, Chadderdon RC, Kompel JF, Kim JS, Gilbertson LG, et al. Quantitative analysis of gene expression in a rabbit model of intervertebral disc degeneration by real-time polymerase chain reaction. Spine J. 2005;5:14-23.
19. Podichetty VK. The aging spine: the role of inflammatory mediators in intervertebral disc degeneration. Cell Mol Biol (Noisy-legrand). 2007;53:4-18.
20. Karna E, Miltyk W, Pałka JA, Jarzabek K, Wołczyński S. Hyaluronic acid counteracts interleukin-1-induced inhibition of collagen biosynthesis in cultured human chondrocytes. Pharmacol Res. 2006;54:275-281.
21. Grant ME. From collagen chemistry towards cell therapy-a personal journey. Int J Exp Pathol. 2007;88:203-214.
22. Xi YM, Hu YG, Lü ZH, Zheng HJ, Chen Y, Qi Z. Gene expression of collagen types IX and X in the lumbar disc. Chin J Traumatol. 2004;7:76-80.
23. Aigner T, Gresk-otter KR, Fairbank JC, von der Mark K, Urban JP. Variation with age in the pattern of type X collagen expression in normal and scoliotic human intervertebral discs. Calcif Tissue Int. 1998;63:263-268.
24. Roberts S, Bains MA, Kwan A, Menage J, Eisenstein SM. Type X collagen in the human invertebral disc: an indication of repair or remodelling? Histochem J. 1998;30:89-95.
25. Boos N, Nerlich AG, Wiest I, von der Mark K, Aebi M. Immunolocalization of type X collagen in human lumbar intervertebral discs during ageing and degeneration. Histochem Cell Biol. 1997; 108:471-480.
26. Xia GP, Liu P, Han YM. [Determination of the total content of astragaloside IV in Radix Astragali.] Zhong Yao Cai. 2008;31:385-387. (text in Chinese with English abstract)
27. Zhang WJ, Hufnagl P, Binder BR, Wojta J. Antiinflammatory activity of astragaloside IV is mediated by inhibition of NF-kappaB activation and adhesion molecule expression. Thromb Haemost. 2003;90:904-914.
28. Wang S, Li J, Huang H, Gao W, Zhuang C, Li B, et al. Anti-hepatitis B virus activities of astragaloside IV isolated from radix Astragali. Biol Pharm Bull. 2009;32:132-135.
29. Zhang ZC, Li SJ, Yang YZ, Chen RZ, Ge JB, Chen HZ. Effect of astragaloside on cardiomyocyte apoptosis in murine coxsackievirus B3 myocarditis. J Asian Nat Prod Res. 2007;9:145-151.
30. Lu S, Zhang J, Yang D. [Effects of Astragaloside in treating myocardial injury and myocardial Sarco/Endoplasmic Ca(2+)-ATPase of viral myocarditis mice.] Zhongguo Zhong Xi Yi Jie He Za Zhi. 1999;19:672-674. (text in Chinese with English abstract)
31. Yin X, Zhang Y, Yu J, Zhang P, Shen J, Qiu J, et al. The antioxidative efects of astragalus saponin I protect against development of early diabetic nephropathy. J Pharmacol Sci. 2006;101:166-173.
32. Xu M, Liu L, Qi C, Deng B, Cai X. Sinomenine versus NSAIDs for the treatment of rheumatoid arthritis: a systematic review and meta-analysis. Planta Med. 2008;74:1423-1429.
33. Liu ZQ, Jiang ZH, Chan K, Zhou H, Wong YF, Bian ZX, et al. Pharmacokinetic interaction of paeoniflorin and sinomenine: pharmacokinetic parameters and tissue distribution characteristics in rats and protein binding ability in vitro. J Pharmacol Sci. 2005;99:381-391.
34. Dai L. [Study on ultrafine vibration extraction technology of Rhizoma Chuanxiong.] Zhongguo Zhong Yao Za Zhi. 2009;34: 977-979. (text in Chinese with English abstract)
35. Cheng CY, Ho TY, Lee EJ, Su SY, Tang NY, Hsieh CL. Ferulic acid reduces cerebral infarct through its antioxidative and anti-inflammatory effects following transient focal cerebral ischemia in rats. Am J Chin Med. 2008;36:1105-1119.
36. Srinivasan M, Sudheer AR, Pillai KR, Kumar PR, Sudhakaran PR, Menon VP. Influence of ferulic acid on gamma-radiation induced DNA damage, lipid peroxidation and antioxidant status in primary culture of isolated rat hepatocytes. Toxicology. 2006;228: 249-258.
37. Islam S, Yoshida H, Matsuki N, Ono K, Nagasaka R, Ushio H, et al. Antioxidant, free radical-scavenging, and NF-kappaB-inhibitory activities of phytosteryl ferulates: structure-activity studies. J Pharmacol Sci. 2009;111:328-337.